GLOW Stock Overview
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. More details
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Glow Lifetech Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.06 |
52 Week High | CA$0.14 |
52 Week Low | CA$0.02 |
Beta | 2.3 |
11 Month Change | 9.09% |
3 Month Change | -7.69% |
1 Year Change | 100.00% |
33 Year Change | -73.91% |
5 Year Change | n/a |
Change since IPO | -90.48% |
Recent News & Updates
Recent updates
Shareholder Returns
GLOW | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 20.0% | -4.9% | 0.04% |
1Y | 100.0% | -32.7% | 22.7% |
Return vs Industry: GLOW exceeded the Canadian Pharmaceuticals industry which returned -32% over the past year.
Return vs Market: GLOW exceeded the Canadian Market which returned 23.3% over the past year.
Price Volatility
GLOW volatility | |
---|---|
GLOW Average Weekly Movement | 26.4% |
Pharmaceuticals Industry Average Movement | 11.9% |
Market Average Movement | 8.3% |
10% most volatile stocks in CA Market | 17.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: GLOW's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: GLOW's weekly volatility has decreased from 53% to 26% over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron.
Glow Lifetech Corp. Fundamentals Summary
GLOW fundamental statistics | |
---|---|
Market cap | CA$7.29m |
Earnings (TTM) | -CA$1.43m |
Revenue (TTM) | CA$554.47k |
13.1x
P/S Ratio-5.1x
P/E RatioIs GLOW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GLOW income statement (TTM) | |
---|---|
Revenue | CA$554.47k |
Cost of Revenue | CA$402.30k |
Gross Profit | CA$152.17k |
Other Expenses | CA$1.59m |
Earnings | -CA$1.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 27.44% |
Net Profit Margin | -258.66% |
Debt/Equity Ratio | 207.0% |
How did GLOW perform over the long term?
See historical performance and comparison